Difference between revisions of "Template:Dopamine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Whywhenwhohow (remove extra plus) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 89: | Line 89: | ||
* [[Norclozapine]]<!--Relatively strong--> | * [[Norclozapine]]<!--Relatively strong--> | ||
* [[Norquetiapine]] | * [[Norquetiapine]] | ||
| − | * [[Olanzapine]]<!--Relatively weak--> ( | + | * [[Olanzapine]]<!--Relatively weak--> ([[olanzapine/fluoxetine|+fluoxetine]]) |
* [[Paliperidone]]<!--Relatively weak--> | * [[Paliperidone]]<!--Relatively weak--> | ||
* [[Quetiapine]] | * [[Quetiapine]] | ||
| Line 129: | Line 129: | ||
* [[Epicriptine]] | * [[Epicriptine]] | ||
* [[Ergocornine]] | * [[Ergocornine]] | ||
| + | * [[Lergotrile]] | ||
* [[Lisuride]] | * [[Lisuride]] | ||
* [[Lysergic acid diethylamide|LSD]] | * [[Lysergic acid diethylamide|LSD]] | ||
| Line 155: | Line 156: | ||
* [[Bifeprunox]] | * [[Bifeprunox]] | ||
* [[Brexpiprazole]] | * [[Brexpiprazole]] | ||
| + | * [[Brilaroxazine]] | ||
* [[Cariprazine]] | * [[Cariprazine]] | ||
* [[F-15063]] | * [[F-15063]] | ||
* [[Lumateperone]] | * [[Lumateperone]] | ||
* [[Norclozapine]] | * [[Norclozapine]] | ||
| − | |||
* ''Others'': [[3-PPP]] | * ''Others'': [[3-PPP]] | ||
| Line 375: | Line 376: | ||
| below = | | below = | ||
| − | * <small>'''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]'' | + | * <small>'''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]''</small> |
| − | * ''[[Template:Adrenergic receptor modulators|Adrenergics]]'' | + | * <small>''[[Template:Adrenergic receptor modulators|Adrenergics]]''</small> |
| − | * ''[[Template:Serotonin receptor modulators|Serotonergics]]'' | + | * <small>''[[Template:Serotonin receptor modulators|Serotonergics]]''</small> |
| − | * ''[[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]]'' | + | * <small>''[[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]]''</small> |
| − | * ''[[Template:Monoamine releasing agents|Monoamine releasing agents]]'' | + | * <small>''[[Template:Monoamine releasing agents|Monoamine releasing agents]]''</small> |
| − | * ''[[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]]'' | + | * <small>''[[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]]''</small> |
| − | * ''[[Template:Monoamine neurotoxins|Monoamine neurotoxins]]''</small> | + | * <small>''[[Template:Monoamine neurotoxins|Monoamine neurotoxins]]''</small> |
}} | }} | ||
Latest revision as of 07:14, 1 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Dopamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Dopamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Dopamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.